Form 4: KORU Medical Systems Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Robert Cascella acquired 5,454 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.
Summary
- On October 1, 2024, Robert Cascella, a director of KORU Medical Systems, Inc., acquired 5,454 shares of common stock at a price of $2.75 per share.
- Following the transaction, Cascella directly owns 70,978 shares of KORU Medical Systems.
- The transaction was reported on a Form 4 filing with the SEC.
Sentiment
Score: 5
Explanation: This is a neutral report of a transaction. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about an insider's stock purchase.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders of a company (such as directors or officers) buy or sell the company's securities. These filings provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence, as it signals that a director is investing in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of the transaction where Robert Cascella acquired shares of KORU Medical Systems. |
| 10/01/2024 | Date of the signature of the Attorney-in-Fact for the filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.